Table Of Content

WORLD DRUG REPORT Volume 2: Statistics 2004 WORLD DRUG REPORT Volume 2: Statistics The Office for Drug Control and Crime Prevention (UNODCCP) became the Office on Drugs and Crime (UNODC) on 1 October 2002. The Office on Drugs and Crime includes the United Nations International Drug Control Programme (UNDCP). United Nations Publication Sales No. E.04.XI.16 ISBN 92-1-148186-4 Volume 2 The boundaries, names and designations used in all maps in this book do not imply official endorsement or acceptance by the United Nations. This publication has not been formally edited. 2004 WORLD DRUG REPORT Volume 2: Statistics Contents Volume I. Analysis Preface Introduction Explanatory notes Executive Summary CHAPTER 1: The world drug problem: A status report 1.1. The policy landscape 1.2. The dynamics of world drug markets 1.2.1. What is the current level of drug use in the world? 1.2.2. How is the drug problem evolving? 1.2.3. The outlook for world drug markets 1.3. Injecting drug use and HIV/AIDS 1.3.1. Extent and characteristics of HIV/AIDS epidemics 1.3.2. HIV transmission among injecting drug users 1.3.3. Measures to respond 1.4. Conceptual advances in drug control 1.4.1. A holistic approach 1.4.2. A more synergetic approach 1.4.3. A more dynamic approach CHAPTER 2: TRENDS 2.1. Opium / Heroin market 2.1.1. Production 2.1.2. Trafficking 2.1.3. Abuse 2.2. Coca / Cocaine market 2.2.1. Production 2.2.2. Trafficking 2.2.3. Abuse 2.3. Cannabis market 2.3.1. Production 2.3.2. Trafficking 2.3.3. Abuse 2.4. Amphetamine-type stimulants market 2.4.1. Production 2.4.2. Trafficking 2.4.3. Abuse Conclusion Volume II. Statistics CHAPTER 3: PRODUCTION 3.1. Opium / Heroin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .205 3.1.1. Afghanistan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .206 3.1.2. Myanmar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .215 3.1.3. Lao PDR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .222 3.1.4. Seizures of illicit laboratories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .228 3.2. Coca / Cocaine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .229 3.2.1. Colombia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .230 3.2.2. Peru . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .239 3.2.3. Bolivia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .245 3.2.4. Seizures of illicit laboratories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .251 3.3. Cannabis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .252 3.3.1. Morocco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .252 3.3.2. Seizures of illicit laboratories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .258 3.4. Amphetamine-type stimulants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .259 3.4.1. Seizures of illicit laboratories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .259 3.5. Other drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .263 3.5.1. Seizures of illicit laboratories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .263 CHAPTER 4: SEIZURES 4.1. Opiates: Seizures, 1997-2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .269 4.2. Cocaine: Seizures, 1997-2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .295 4.3. Cannabis: Seizures, 1997-2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .304 4.4. Amphetamine-type stimulants: Seizures, 1997-2002 . . . . . . . . . . . . . . . . . . . .331 CHAPTER 5: PRICES 5.1. Opiates: Wholesale, street prices and purity levels . . . . . . . . . . . . . . . . . . . . . .363 5.2. Cocaine: Wholesale, street prices and purity levels . . . . . . . . . . . . . . . . . . . . . .369 5.3. Cannabis: Wholesale, street prices and purity levels . . . . . . . . . . . . . . . . . . . . .373 5.4. Amphetamine-type stimulants: Wholesale, street prices and purity levels . . . .379 CHAPTER 6: CONSUMPTION 6.1. Annual prevalence of drug abuse 6.1.1. Opiates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .389 6.1.2. Cocaine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .392 6.1.3. Cannabis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .394 6.1.4. Amphetamine-type stimulants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .397 6.1.5. Ecstasy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .400 6.2. Treatment demand (primary drugs of abuse) . . . . . . . . . . . . . . . . . . . . . . . . . .403 Methodology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .409 3. PRODUCTION